Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Design, Synthesis, and Antifungal Analysis of Pyrazoline Derivatives Against Candida Species: A Comprehensive In Vitro and In Silico Approach

Indonesian Journal of Chemistry · Vol. 25 No. 4 (2025) · hlm. 1226–1226

DOI
10.22146/ijc.105255
ISSN
1411-9420, 2460-1578
Terbit
2025-07-31
Penerbit
Gadjah Mada University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-nd/4.0/

Abstrak

This study utilized in vitro and in silico methods to assess the antifungal efficacy of synthesized pyrazoline derivatives (4a–e) against Candida species. The compounds were produced by a one-pot process and structurally analyzed using spectroscopic methods. The antifungal efficacy was evaluated against C. albicans, C. glabrata, and C. krusei using minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) assays. Among the derivatives, compound 4e exhibited potent antifungal action, displaying MIC values similar to ketoconazole. Molecular docking and pharmacophore modeling have shown that 4e interacts efficiently with critical residues of lanosterol 14α-demethylase (CYP51). The density functional theory (DFT) study indicated advantageous electrical characteristics, while molecular dynamics simulations validated the structural stability of the 4e–CYP51 complex, evidenced by low RMSD and RMSF values, along with an MM/GBSA binding energy comparable to that of ketoconazole. A robust association between binding energy and MIC substantiates the predictive use of computational data. The results suggest that compound 4e replicates the binding characteristics of ketoconazole and may be a viable candidate for antifungal medication development. This integrative strategy reinforces the justification for additional optimization and preclinical assessment of pyrazoline-based antifungal drugs aimed at CYP51.

Kata kunci

Jaringan kolaborasi para penulis

31 penulis · 98 tautan kepenulisan bersama · 42 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Riau University
  • Sekolah Tinggi Ilmu Farmasi Riau
  • Padjadjaran University
  • Universitas Islam Negeri Sultan Syarif Kasim Riau
  • Universitas Bhakti Kencana
  • Gunadarma University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Jasril JasrilRiau University5
Yum EryantiRiau University3
Adel ZamriRiau University2
Ihsan IkhtiaruddinAfiliasi tidak diketahui2
Yuni FatisaUniversitas Islam Negeri Sultan Syarif Kasim Riau2
Arif YasthophiUniversitas Islam Negeri Sultan Syarif Kasim Riau2
Elviyenti ElviyentiUniversitas Islam Negeri Sultan Syarif Kasim Riau2
Aisyah AisyahGunadarma University2
Nurlaili NurlailiRiau University2
Unang SupratmanPadjadjaran University2
Christine JoseAfiliasi tidak diketahui1
Ganis Fia KartikaAfiliasi tidak diketahui1
Nofal HerfindoSekolah Tinggi Ilmu Farmasi Riau1
Ihsan IkhtiarudinSekolah Tinggi Ilmu Farmasi Riau1
Ihsan IktiarudinAfiliasi tidak diketahui1
Nisa UlhukmiRiau University1
Riryn NoviantyRiau University1
Mhd Muslim SyaifullahRiau University1
Tati HerlinaPadjadjaran University1
Rani MaharaniPadjadjaran University1
Deden Indra DinataUniversitas Bhakti Kencana1
Melzi OctavianiSekolah Tinggi Ilmu Farmasi Riau1
Winda Yusma AmeliahSekolah Tinggi Ilmu Farmasi Riau1
Meiriza DjohariSekolah Tinggi Ilmu Farmasi Riau1
Haiyul FadhlıSekolah Tinggi Ilmu Farmasi Riau1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764840418, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Design, Synthesis, and Antifungal Analysis of Pyrazoline Derivatives Against Candida Species: A Comprehensive In Vitro and In Silico Approach</dc:title><dc:creator>Muhammad Rohim</dc:creator><dc:creator>Yuli Haryani</dc:creator><dc:creator>Neni Frimayanti</dc:creator><dc:creator>Fauzan Zein Muttaqin</dc:creator><dc:creator>Hilwan Yuda Teruna</dc:creator><dc:creator>Rudi Hendra</dc:creator><dc:subject>pyrazoline derivatives</dc:subject><dc:subject>antifungal agents</dc:subject><dc:subject>Candida albicans</dc:subject><dc:subject>Candida glabrata</dc:subject><dc:subject>Candida krusei</dc:subject><dc:subject>lanosterol 14α-demethylase</dc:subject><dc:subject>CYP51</dc:subject><dc:subject>minimum inhibitory concentration</dc:subject><dc:subject>minimum fungicidal concentration</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>pharmacophore modeling</dc:subject><dc:subject>density functional theory</dc:subject><dc:subject>molecular dynamics simulation</dc:subject><dc:subject>MM-GBSA binding free energy</dc:subject><dc:subject>one-pot synthesis</dc:subject><dc:description xml:lang="en">This study utilized in vitro and in silico methods to assess the antifungal efficacy of synthesized pyrazoline derivatives (4a–e) against Candida species. The compounds were produced by a one-pot process and structurally analyzed using spectroscopic methods. The antifungal efficacy was evaluated against C. albicans, C. glabrata, and C. krusei using minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) assays. Among the derivatives, compound 4e exhibited potent antifungal action, displaying MIC values similar to ketoconazole. Molecular docking and pharmacophore modeling have shown that 4e interacts efficiently with critical residues of lanosterol 14α-demethylase (CYP51). The density functional theory (DFT) study indicated advantageous electrical characteristics, while molecular dynamics simulations validated the structural stability of the 4e–CYP51 complex, evidenced by low RMSD and RMSF values, along with an MM/GBSA binding energy comparable to that of ketoconazole. A robust association between binding energy and MIC substantiates the predictive use of computational data. The results suggest that compound 4e replicates the binding characteristics of ketoconazole and may be a viable candidate for antifungal medication development. This integrative strategy reinforces the justification for additional optimization and preclinical assessment of pyrazoline-based antifungal drugs aimed at CYP51.</dc:description><dc:publisher>Gadjah Mada University</dc:publisher><dc:date>2025-07-31</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.22146/ijc.105255</dc:identifier><dc:identifier>10.22146/ijc.105255</dc:identifier><dc:source>Indonesian Journal of Chemistry; Vol 25 No 4 (2025); 1226-1226</dc:source><dc:source>1411-9420</dc:source><dc:source>2460-1578</dc:source><dc:language>en</dc:language><dc:relation>https://journal.ugm.ac.id/ijc/article/download/105255/41960</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights></oai_dc:dc>